PNC Financial Services Group’s Sierra Oncology, Inc. Common Stock SRRA Stock Holding History

PNC Financial Services Group’s Portfolio SRRA Stock Details SRRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-212	Closed	-$4K	–	4160
2019 Q2	$4K	Hold	212	–	–	﹤0.01%	3805
2019 Q1	$14K	Hold	212	–	–	﹤0.01%	3507
2018 Q4	$12K	Sell	212 -697	-77%	-$44.5K	﹤0.01%	3504
2018 Q3	$61K	Hold	909	–	–	﹤0.01%	2885
2018 Q2	$109K	Hold	909	–	–	﹤0.01%	2539
2018 Q1	$76K	Buy	909 +327	+56%	+$37.1K	﹤0.01%	2714
2017 Q4	$87K	Hold	582	–	–	﹤0.01%	2648
2017 Q3	$36K	Hold	582	–	–	﹤0.01%	3107
2017 Q2	$27K	Sell	582 -18,086	-97%	-$923K	﹤0.01%	3204
2017 Q1	$1.14M	Hold	18,668	–	–	﹤0.01%	1231
2016 Q4	$1.11M	Buy	18,668 +983	+6%	+$61.3K	﹤0.01%	1228
2016 Q3	$1.29M	Buy	17,685 +2,658	+18%	+$205K	﹤0.01%	1170
2016 Q2	$1.2M	Buy	15,027 +655	+5%	+$125K	﹤0.01%	1180
2016 Q1	$3.87M	Buy	+14,372	New	+$4.59M	﹤0.01%	699

Other funds holding SRRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NLVP

New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.24B AUM 41.74% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

PNC Financial Services Group's SRRA Position: Q3 2019 in Review

PNC Financial Services Group sold out of Sierra Oncology, Inc. Common Stock (SRRA) in Q3 2019, closing a stake of 212 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in SRRA in Q1 2016 and held it in 14 quarters. The position peaked at $3.87M in Q1 2016. 45 funds tracked by Wall St. Rank hold SRRA as of Q3 2019.

PNC Financial Services Group reported no remaining Sierra Oncology, Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
PNC Financial Services Group sold 212 Sierra Oncology, Inc. Common Stock shares in Q3 2019, an estimated $4K.
PNC Financial Services Group first reported a position in Sierra Oncology, Inc. Common Stock in Q1 2016 and held it in 14 quarters.
PNC Financial Services Group's Sierra Oncology, Inc. Common Stock position peaked at $3.87M in Q1 2016.
45 funds tracked by Wall St. Rank held Sierra Oncology, Inc. Common Stock as of Q3 2019.

Based on PNC Financial Services Group's 13F filing for Q3 2019, filed 8 Nov 2019.